Bal Pharma Limited (BOM:524824)

Bal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	1,395	957	1,314	1,432	1,050	1,599
Market Cap Growth	-8.97%	-27.15%	-8.20%	36.34%	-34.31%	100.65%
Enterprise Value	2,958	2,415	2,637	2,758	2,031	2,587
Last Close Price	87.65	60.14	82.04	89.23	64.76	103.32

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	22.19	15.24	18.22	19.37	40.83	28.49
PS Ratio	0.45	0.31	0.43	0.42	0.35	0.57
PB Ratio	1.70	1.16	1.70	1.99	1.65	2.73
P/TBV Ratio	2.15	1.47	1.81	2.14	1.79	2.93
P/FCF Ratio	11.74	8.05	86.00	12.11	-	8.72
P/OCF Ratio	4.58	3.15	6.47	6.28	-	5.97

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	0.95	0.78	0.87	0.81	0.67	0.92
EV/EBITDA Ratio	9.27	7.57	10.23	9.75	8.54	11.77
EV/EBIT Ratio	14.20	11.60	13.17	12.75	11.66	17.33
EV/FCF Ratio	24.88	20.32	172.55	23.32	-	14.12

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	1.94	1.94	1.97	1.98	2.09	1.82
Debt / EBITDA Ratio	5.00	5.00	5.61	4.84	5.40	4.68
Debt / FCF Ratio	13.42	13.42	99.67	12.03	-	5.82
Net Debt / Equity Ratio	1.83	1.83	1.83	1.70	1.97	1.72
Net Debt / EBITDA Ratio	4.71	4.71	5.51	4.32	5.28	4.59
Net Debt / FCF Ratio	12.64	12.64	92.85	10.34	-7.76	5.50
Asset Turnover	0.88	0.88	0.93	1.07	1.06	1.12
Inventory Turnover	1.44	1.44	1.71	2.13	2.07	2.56
Quick Ratio	0.41	0.41	0.48	0.61	0.50	0.52
Current Ratio	1.05	1.05	1.07	1.15	1.09	1.11
Return on Equity (ROE)	7.92%	7.92%	9.69%	10.98%	4.29%	10.20%
Return on Assets (ROA)	3.66%	3.66%	3.82%	4.27%	3.80%	3.73%
Return on Invested Capital (ROIC)	9.12%	9.22%	9.68%	9.28%	5.51%	5.76%
Return on Capital Employed (ROCE)	16.50%	16.50%	17.20%	18.50%	16.80%	15.70%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	4.50%	6.56%	5.49%	5.16%	2.45%	3.51%
FCF Yield	8.52%	12.42%	1.16%	8.26%	-15.41%	11.46%
Dividend Yield	1.37%	1.99%	1.46%	1.34%	1.54%	0.97%
Payout Ratio	30.40%	30.40%	26.48%	21.22%	60.55%	26.41%
Buyback Yield / Dilution	-0.35%	-0.35%	-0.74%	-0.30%	-5.86%	-4.39%
Total Shareholder Return	1.02%	1.65%	0.73%	1.04%	-4.31%	-3.42%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error